April is National Autism Acceptance Month 💙 ProAct partnered with The Arc Jefferson - St. Lawrence for the Autism Acceptance Walk, an event that celebrates and honors the experiences and identities of Autistic individuals. Thank you to our employee owners who joined others while walking in support of understanding, accepting, and raising awareness of Autism. Together, we can continue to drive positive change and inclusivity! #ProActCares #AutismAwareness #StrongerTogether #AutismAcceptance #EmployeeOwned
关于我们
At ProAct, we strive to produce innovative, affordable and flexible prescription drug benefit solutions for the client by combining industry leading client service with the latest in PBM technology. And to us, those solutions go far beyond medications. We’re here to work with you personally, as a partner, to implement the right plan and help you make informed decisions that are best for your business, your bottom line and the health of your employees. Who is ProAct? ProAct is a fully integrated Pharmacy Benefit Management Company providing benefits since 1999. We are 100% employee owned, with over 3,000 employees nationwide who are dedicated to providing you with industry-leading “high-touch” customer support. We aim to serve midmarket sized employer that are often underserved. Why ProAct? From innovative cost containment programs to high-touch client and member services- our clients are covered under our care. We are employee owned, so there is never a worry that your plan will be bought or sold. Client Services ProAct has a team of customer support representatives that are there to answer your questions, 24 hours a day, 7 days a week. Our implementation team will work closely with your team to ensure that the transition will be seamless. Once on board, you will have direct access to our dedicated account management team, who will ensure that your plan meets the needs of your business and the needs of your members. Custom Trend Management When you work with ProAct, we work as your partner to ensure that you are getting the best plan and services for your money. We own our own state of the art mail order and specialty pharmacies, allowing us complete control over costs savings to your plan. We offer a variety of services to ensure that your costs stay low, including our Therapeutic Alternative Program, International Mail Order, quarterly reviews, and much more. Contact Us Sales@proactrx.com 1-888-254-3552
- 网站
-
https://secure.proactrx.com/
ProAct - PBM的外部链接
- 所属行业
- 医院和医疗保健
- 规模
- 1,001-5,000 人
- 总部
- East Syracuse，NY
- 类型
- 私人持股
- 创立
- 1999
- 领域
- Customized Pharmacy Benefit Management、High Touch Service Model、Employee Owned - No mergers to worry about、Integrated Mail Order Service and Specialty Pharmacy和Organic Growth
地点
ProAct - PBM员工
动态
-
ProAct is a proud corporate sponsor for LEGS Dallas Chapter. Our very own, Suzi Huffman, MHA is joining a community where golf meets networking, friendship, and empowerment! ⛳
We extend our heartfelt gratitude to ProAct Pharmacy Benefit Management for their generous corporate sponsorship for LEGS Dallas 2025. As a 100% employee-owned pharmacy benefit partner, ProAct exemplifies a commitment to high-touch service and flexible solutions. 💊 A special thank you to Suzi Huffman, MHA, Southwest Regional Sales Director, whose dedication and leadership have been instrumental in making this collaboration possible. With a diverse background that includes 30 years of military service. We encourage all our ladies to follow ProAct and Suzi Huffman on their social media platforms to stay informed about their innovative pharmacy benefit solutions. Let's show our support for a partner that truly values community and excellence. 💚 #LEGSGolfDallas #ProActPharmacyBenefitManagement #PharmaceuticalServices #CorporatePartnership
-
-
Are you interested in learning more about the PBM industry? 💊 Do you enjoy helping others? Can you stay cool under pressure? Apply today to become a Customer Service Representative at ProAct! 📞 Assist others from the comfort of your home, apply here: https://hubs.li/Q03fJPKs0 We offer a competitive salary and benefits package, including 401(k), stock ownership, medical, dental, vision, and prescription drug coverage with paid time off and holiday pay. #ProActPBM #NowHiring #CustomerService #RemoteWork #EmployeeOwned
-
-
At ProAct, we continue to enable affordable access to biosimilars and help ensure a smooth transition for patients starting these innovative products. Our thoughtful and comprehensive approach to include inflammatory biosimilars on our Advantage and Core formularies is projected to deliver thousands in plan cost savings by the end of 2025. Effective March 21st, ProAct will prefer the following STELARA® (USTEKINUMAB) biosimilar products on its Advantage and Core formularies, in addition to other inflammatory products based on indication: • SELARSDI™ (ustekinumab-aekn subcutaneous injection) by Teva • USTEKINUMAB-TTWE (subcutaneous injection) by Quallent • YESINTEK™ (ustekinumab-kfce subcutaneous injection) by Biocon STELARA® will continue to be covered through 2025 on Advantage and Core formularies.
-
-
Employee owners proudly joined thousands of walkers in the fight against heart disease and stroke at the 2025 American Heart Association Syracuse Heart Walk. ❤️ It was a day filled with inspiration, energy, and unity! Throughout the month of February, employee owners participated in a Valentine's E-Card fundraiser to show appreciation to their fellow co-workers. The funds raised were directly donated to support the American Heart Association's efforts towards life-saving research and educational programs. #ProActCares #HeartWalk #HeartHealth #StrongerTogether #EmployeeOwned
-
-
Our very own Suzi Huffman, MHA will be representing ProAct in her home state at the 2025 NABIP Texas Annual Conference. 🗣️ If you'll be in attendance, be sure to seek out Suzi to learn about ProAct's game-changing approach to Pharmacy Benefit Management! 💊 #ProActPBM #NABIP #PharmacyBenefits #EmployeeOwned
-
-
🚨 We are exactly two weeks away from the Texas Association of Benefit Administrators 2025 Spring Conference in Round Rock, Texas. Our very own Michael Howard and David Mastrangelo MBA will be presenting on 'Embracing Digital Transformation within PBM' and we can't wait! During Session 2A on Wednesday, April 16th, Michael and David will speak on the importance of leveraging people, process, and technology to meet the current market, all while retaining core values. They will also touch on what the future of pharmacy will look like with the implementation of AI. 🖥️ #ProActPBM #TABA #PharmacyBenefits #EmployeeOwned #DigitalHealth #AI
-
-
The ProAct Clinical Team is excited to announce our partnership with Aprexis! This platform allows us to streamline our Medication Therapy Management program and positively impact our members' health outcomes while lowering plan spend.
ProAct Partners with Aprexis to Drive Enhanced Health Outcomes and Cost Savings with Advanced Medication Therapy Management and Clinical Gaps in Care Solutions Syracuse, NY – April 1, 2025 ProAct, a leading Pharmacy Benefit Manager (PBM) serving over 700,000 lives nationwide, is proud to announce its strategic partnership with Aprexis, a cutting-edge Medication Therapy Management (MTM) software provider. This collaboration is aimed at optimizing the use of medications, improving patient care quality, reducing healthcare costs, and minimizing medication-related adverse events. With Aprexis’ innovative platform, ProAct will be able to streamline MTM processes, deliver actionable client reporting, and scale its clinical offerings across its extensive client base. ProAct selected Aprexis after an extensive evaluation of available MTM software platforms. Aprexis was selected for its robust and versatile platform, which delivers a highly customizable, intuitive solution that supports a wide range of clinical functions. FOR MORE INFO, check out our joint Press Release below.
-
On March 20, 2025, Johnson & Johnson’s Tremfya® (guselkumab) received FDA approval for a label expansion for the treatment of Crohn’s Disease (CD). Tremfya® is the first and only interleukin (IL)-23 inhibitor offering both subcutaneous and intravenous induction options for adult patients with moderately to severely active Crohn’s disease. This approval marks the fourth indication for Tremfya® in the U.S., following moderate-to-severe plaque psoriasis in July 2017, active psoriatic arthritis in July 2020, and moderately to severely active ulcerative colitis in September 2024. https://hubs.li/Q03dR8C-0
-
-
ProAct is hiring for a Pharmacy Resident to join our team! 💊 The Pharmacy Resident will have the opportunity to experience learning opportunities across all aspects of ProAct and pharmacy benefit management. At the end of the one-year non-accredited program, the resident will possess knowledge on drug utilization management, data analysis, formulary management, clinical account management, and Medication Therapy Management. This position is an excellent way to gain hands-on experience within managed care pharmacy. Click the link to apply today: https://hubs.li/Q03dv7tB0 #PharmacyResident #ProActPBM #EmployeeOwned #NowHiring
-